| |
|
|
|
Cytosorbents Corporation  
|
|
9.08 -0.23 (-0.02%) |
12-10 16:00 |
|
Open: |
9.31 |
Pre close: |
9.31 |
Target:
|
12.54
|
|
High: |
9.4348 |
Low: |
9.01 |
Resistance:
|
10.74
12.00
|
|
Volume: |
134,949 |
Market Cap: |
287M |
Support:
|
8.70
7.24
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
9.68
 |
MACD |
MACD(12,26):
|
-0.22 |
|
MA(20): |
10.00 |
Signal(12,26,9): |
-0.13 |
|
MA(100): |
11.56 |
Stochastic Oscillator |
%K(14,3):
|
15.37 |
|
MA(250): |
9.80  |
%D(3): |
29.89 |
|
Average Volume(K) |
3-Month: |
19929
|
52-Week |
High:
|
14.95 |
|
10-Days: |
14584 |
Low: |
5.80 |
|
RSI |
RSI(14):
|
36.25 |
Change(%): |
36.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.510 |
Return on Equity (ttm) |
-101.2 |
Shares Out. (M) |
31.65 |
|
EPS Est. Current Year |
-0.270 |
Return on Assets (ttm) |
-53.0 |
Shares Float (M) |
12.48 |
|
EPS Est. Next Year |
-0.280 |
PEG Ratio |
0.00 |
% Held by Insiders |
63.90 |
|
EPS Est. Next Quarter |
-0.110 |
Qtrly Rev. Growth |
50.2 |
% Held by Institutions |
38.70 |
|
Forward EPS |
-0.120 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
15.230 |
EBITDA (p.s.) |
0.000 |
P/E |
-17.80 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.60 |
|
Profit Margin |
-76.98 |
Operating Cash Flow
(M) |
-8.54 |
P/S |
410545696.00 |
|
Operating Margin |
-65.52 |
Levered Free Cash Flow
(M) |
-6.19 |
P/CF |
-33.65 |
|
|
|
|
|
|
